Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07528664

Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking During Pregnancy.

Nearly one in five pregnant women still smoke in the third trimester of pregnancy. This is the highest rate in Europe. Smoking during pregnancy is an established risk factor for the unborn child: risk of ectopic pregnancy, intrauterine growth restriction and prematurity, risk of sudden infant death syndrome (increased two- to threefold), and risk of respiratory problems for the newborn. The risks increase with the frequency and duration of the mother's smoking during pregnancy.

Quitting smoking is essential to prevent the risks associated with tobacco use during pregnancy. The evidence of benefits for the child from pharmacotherapeutic interventions (nicotine replacement therapy) is insufficient. New treatment options must be explored to help pregnant women quit smoking.

Financial incentives are recognized as an effective means of motivating behavior change. It is about impacting the trade-off of quitting smoking. The trade-off consists of the benefits of quitting (improved health and reduced monetary costs because tobacco is no longer purchased) and the costs of quitting (suppressing the satisfaction and pleasure derived from smoking). One consortium member conducted a large clinical trial showing that a financial incentive is an effective intervention to help pregnant women who smoke to quit smoking.

Previous studies have shown that 70% of partners of women who use tobacco are themselves smokers. The partner's smoking is a risk factor for continued tobacco use during pregnancy and can be a source of passive smoking for the mother and child. Women who quit smoking before and after pregnancy are more often in relationships with nonsmoking partners than those who continue to smoke.

The investigator hypothesize that a financial incentive aimed at the partner's abstinence from tobacco will enhance the beneficial effects of the financial incentive on reducing or stopping tobacco use during pregnancy. The investigator also hypothesize that incentivizing the partner to stop smoking will help strengthen their engagement in family life.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier Universitaire de Lille

Lille, Haut-de-France, 59000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Consent to participate in the study
  • Agree to monthly prenatal follow-up at the maternity unit
  • Understand French
  • Are enrolled in health insurance or benefit from AME (Aide Médicale d'État)
  • 18 years of age or older

Exclusion criteria

  • Who do not wish to quit smoking
  • Whose partner does not wish to quit smoking
  • Who use electronic cigarettes in a complementary or exclusive manner (not applied to the partner) at inclusion
  • Who will separate from the father of the unborn child and/or no longer cohabit with him
  • Who will not be able to participate in the entirety of the study (e.g., planning to move after the birth of the child)
  • Who do not wish to give birth in one of the study maternities.

Treatment and study plan

Financial incentive contingent on tobacco abstinence.

Behavioral

Financial incentive conditioned on tobacco abstinence targeting the pregnant woman and the smoking partner to reduce tobacco use during pregnancy, compared with no financial incentive for the couple and with a financial incentive targeting only the pregnant woman.

Standar care

Radiation

In the control group, parental care will be in line with current practices in the maternity ward and with the recommendations of Santé publique France in force at the start of the study.

Primary outcomes

  1. Tobacco use

    Time frame: Birth of the child

    Number of months the pregnant woman has abstained from smoking from enrollment (12th to 16th week) until birth.

Study contacts

Contact information is provided by the study sponsor or research team.

Roxane VANSPRANGHELS-GIBERT Hospital Practitioner, MD,PhD

CONTACT

[email protected]

+33 320446799

Sponsors and collaborators

Lead sponsor

University Hospital, Lille

Other

Registry information

Official study title

Randomized, Multicenter, Regional Study in 3 Parallel Arms to Evaluate the Effectiveness of a Prevention Program Based on a Financial Incentive Aimed at the Pregnant Woman and Her Smoking Partner, Designed to Reduce Tobacco Consumption During Pregnancy.

Acronym: PREVENT

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Apr 14, 2026
Registry last updated
Apr 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.